Physician profile
Christopher Bibbo
NPI 1609974443
$615,382.76
in general payments reported to CMS, 2019-2025
32 companies · $142K in 2025
The $142K reported for 2025 was more than what 98% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $2,857 · 2021: $56K · 2022: $220K · 2023: $82K · 2024: $87K · 2025: $142K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $162K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $95K · Travel and Lodging: $24K · Acquisitions: $17K · Food and Beverage: $7,424 · Royalty Or License: $4,692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $162,463.31 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $94,651.00 |
| Travel and Lodging | $24,430.35 |
| Acquisitions | $17,487.07 |
| Food and Beverage | $7,424.44 |
| Royalty Or License | $4,691.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $274,107.65 | 2019-2025 | Truelok, Xcaliber External Fixator, Truelok Evo |
| Sanara Medtech INC. | $149,032.53 | 2021-2025 | Celleraterx, Celleraterx, Biasurge |
| Linvatec Corporation | $147,310.33 | 2022-2025 | Avenger Radial Head, +4 Stems, 5ms |
| Kci USA, INC. | $10,602.15 | 2019-2020 | |
| Axogen | $10,123.53 | 2019 | |
| Gramercy Extremity Orthopedics LLC | $10,030.20 | 2020-2025 | |
| Bone Support INC. | $7,310.25 | 2020-2022 | |
| New Standard Device, LLC Dba Metalogix | $2,500.00 | 2022 | |
| Stryker Corporation | $938.62 | 2019-2025 | Infinity Adaptis, Infinity |
| Smith+Nephew, INC. | $931.68 | 2021-2025 | Oasis, Grafix Pl, Stravix Pl |
| Organogenesis INC. | $517.12 | 2019 | |
| Avita Medical Americas, LLC | $309.37 | 2024-2025 | Permeaderm, Cohealyx, Recell |
| Globus Medical, INC. | $288.17 | 2024-2025 | Precice® Intramedullary Limb Lengthening System, Creo One Robotic Screw, Mars 3v/3vl |
| Abbvie INC. | $178.73 | 2021-2025 | Teflaro |
| Davol INC. | $151.23 | 2025 | Phasix Mesh |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $143.75 | 2020-2022 | |
| Kerecis Limited | $143.27 | 2019 | |
| Trilliant Surgical LLC. | $137.49 | 2023 | Arsenal Ankle 10 Hole 1/3 Tubular Plate |
| Supreme Orthopedic Systems, LLC | $125.00 | 2021 | |
| Checkpoint Surgical, INC | $91.41 | 2021 | |
| In2bones USA, LLC | $80.52 | 2022 | |
| Depuy Synthes Sales INC. | $67.81 | 2023 | Na, Vivigen Mis Delivery System, Unium |
| Arteriocyte Medical Systems, INC. | $48.02 | 2019 | |
| Allergan, INC. | $42.49 | 2019-2022 | |
| Paragon 28, INC. | $37.76 | 2024 | Monkey Rings |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $25.26 | 2024 | |
| Bioventus LLC | $22.54 | 2022 | |
| Nevro Corp. | $21.61 | 2019 | |
| Melinta Therapeutics, LLC | $17.66 | 2024 | Rezzayo, Kimyrsa |
| Anika Therapeutics, INC. | $17.49 | 2024 | Integrity |
| Ethicon US, LLC | $14.99 | 2024 | Stratafix |
| Heraeus Medical, LLC. | $14.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$350,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Bibbo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.